4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000037
CFO & Chief Business Officer sold 33,266 shares at an average $1.70 ($56,620)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO & Chief Business Officer | 2025-01-21 | Sale 10b5-1 | −4,364 | $1.60 | $6,986 | 260,646 | D |
| Zuga Matt CFO & Chief Business Officer | 2025-01-23 | Sale 10b5-1 | −28,902 | $1.72 | $49,633 | 231,744 | D |
| Open-market sales · 33,266 sh · avg $1.70 · $56,620 | |||||||
Loading xslF345X05/wk-form4_1737685161.xml…